Aarey Drugs Pharmaceuticals Ltd vs Trident Lifeline Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Aarey Drugs & Pharmaceuticals Ltd is ₹ 88.45 as of 18 May 15:30 . The P/E Ratio of Aarey Drugs & Pharmaceuticals Ltd changed from 0 on March 2022 to 0 on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe P/E Ratio of Trident Lifeline Ltd changed from 30.4 on March 2023 to 25.1 on March 2025 . This represents a CAGR of -6.19% over 3 years The Market Cap of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore on March 2022 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 4 yearsThe Market Cap of Trident Lifeline Ltd changed from ₹ 182.95 crore on March 2023 to ₹ 295.53 crore on March 2025 . This represents a CAGR of 17.33% over 3 years The revenue of Aarey Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Trident Lifeline Ltd for the Mar '26 is ₹ 50.26 crore as compare to the Dec '25 revenue of ₹ 30.34 crore. This represent the growth of 65.66% The ebitda of Aarey Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Trident Lifeline Ltd for the Mar '26 is ₹ 12.91 crore as compare to the Dec '25 ebitda of ₹ 9.72 crore. This represent the growth of 32.82% The net profit of Aarey Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Trident Lifeline Ltd changed from ₹ 1.6 crore to ₹ 6.87 crore over 8 quarters. This represents a CAGR of 107.21% The Dividend Payout of Aarey Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Trident Lifeline Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs & Pharmaceuticals Limited was originally incorporated on May 15, 1990 as a private limited company in Mumbai with the name Niharika Textiles & Chemicals Private Limited.
The company was originally promoted by Prakash Mandhana, Kavita Mandhana and Neeta Mandhana.
In March, 1993, the Aarey Group of companies belonging to Ghatalia family took over the Company and it was converted into public limited company.
Also, the name of the company was changed from Niharika Textiles & Chemicals Private Limited to Aarey Drugs & Pharmaceuticals Limited. The Company is one of the manufacturer and suppliers of pharmaceutical raw materials, Chemicals, Pharmaceuticals ingredients, API's Drugs, Food Colours and Flavours.
The company is engaged in the business of manufacturing, selling of drugs & pharmaceutical products and is governed by a number of central and state legislations that regulate the business.

About Trident Lifeline Ltd

Trident Lifeline Limited was originally incorporated as Private Limited Company as 'Trident Lifeline Private Limited' on January 09, 2014.
Subsequently, Company converted into a Public Limited and the name of Company was changed to 'Trident Lifeline Limited' on June 10, 2022.
The Company is engaged in business of marketing ethical pharmaceutical products in domestic as well as international market.
It is also engaged in distribution of pharmaceutical products through third party distribution network. Apart from these, the Company offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license.
It operate in India as well as African, Latin American and East Indian Countries.

FAQs for the comparison of Aarey Drugs & Pharmaceuticals Ltd and Trident Lifeline Ltd

Which company has a larger market capitalization, Aarey Drugs & Pharmaceuticals Ltd or Trident Lifeline Ltd?

Market cap of Aarey Drugs & Pharmaceuticals Ltd is 258 Cr while Market cap of Trident Lifeline Ltd is 302 Cr

What are the key factors driving the stock performance of Aarey Drugs & Pharmaceuticals Ltd and Trident Lifeline Ltd?

The stock performance of Aarey Drugs & Pharmaceuticals Ltd and Trident Lifeline Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aarey Drugs & Pharmaceuticals Ltd and Trident Lifeline Ltd?

As of May 18, 2026, the Aarey Drugs & Pharmaceuticals Ltd stock price is INR ₹90.99. On the other hand, Trident Lifeline Ltd stock price is INR ₹253.5.

How do dividend payouts of Aarey Drugs & Pharmaceuticals Ltd and Trident Lifeline Ltd compare?

To compare the dividend payouts of Aarey Drugs & Pharmaceuticals Ltd and Trident Lifeline Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.